Oryzon Genomics SA announced the appointment of Gregory L. Weaver as executive vice president and chief financial officer, effective January 12, 2015. Weaver will report directly to Carlos Buesa, president and chief executive officer of Oryzon, and will be based at Oryzon's U.S. headquarters, located at 245 First Street in Cambridge, MA. Weaver has served as CFO Fibrocell Science.

Previous to Fibrocell, Weaver was CFO at Celsion Corp, Poniard Pharmaceuticals and Sirna Therapeutics. He also currently serves as non-executive director of Egalet Corporation and Atossa Genetics. Oryzon's Mr. Enric Rello will remain as CFO in Spain and will continue as part of Oryzon's senior management team to support the company's financial operations in Spain.